FdaApplication
NDA 220381
Identifiers
- fda_app_no: NDA220381
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2026-07-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | 4.32GM/20ML (216MG/ML) | SOLUTION;INTRAVENOUS |
| GLYCOPHOS | SODIUM GLYCEROPHOSPHATE | 21.6GM/100ML (216MG/ML) | SOLUTION;INTRAVENOUS |
2 products